• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchMoonLake Immunotherapeutics
    Picture of MoonLake Immunotherapeutics logo

    MLTX — MoonLake Immunotherapeutics News Story

    $12.570.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapSucker Stock
    • Market Cap
      $1.07bn
    • Enterprise Value
      $632.28m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • MLTX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    MLTX Dividends
    All News

    NASDAQ RESUMED AT 07:30 AM

    Picture of MoonLake Immunotherapeutics logoMoonLake Immunotherapeutics
    04/10/2021 12:30
    NASDAQ RESUMED  HLXA.O  AT 07:30 AM
    

    Recent news on MoonLake Immunotherapeutics

    See all news
    • MoonLake jumps as AbbVie's weak skin drug data eases competition fears

      22/10/2026 17:17
    • Brief: Moonlake Immunotherapeutics Files For Mixed Shelf Offering, Size Not Disclosed

      10/08/2026 23:02
    • MoonLake Immunotherapeutics reports results for the quarter ended June 30 - Earnings Summary

      10/08/2026 14:32
    • MoonLake's psoriatic arthritis drug meets key goals in late-stage trial (updated)

      10/08/2026 13:58
    • MoonLake's psoriatic arthritis drug meets key goals in late-stage trial

      10/08/2026 13:05

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.